Value-based flow testing of chronic lymphoproliferative disorders: a quality improvement project to develop an

Matthew J Oberley1, Sean Fitzgerald2, David T Yang1

  • 1From the Department of Pathology and Laboratory Medicine, Children's Hospital of Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles;

Summary

Developing a cost-effective flow cytometry strategy for lymphoproliferative disorders (LPDs) can reduce antibody use. This approach uses patient data to screen for LPDs, focusing on common CD5-positive types.